Financials data is unavailable for this security.
View more
Year on year Otsuka Holdings Co Ltd had net income fall -9.18% from 133.91bn to 121.62bn despite a 16.14% increase in revenues from 1.74tn to 2.02tn.
Gross margin | 70.66% |
---|---|
Net profit margin | 6.01% |
Operating margin | 6.20% |
Return on assets | 3.76% |
---|---|
Return on equity | 5.02% |
Return on investment | 4.70% |
More ▼
Cash flow in JPYView more
In 2023, Otsuka Holdings Co Ltd increased its cash reserves by 8.84%, or 41.71bn. The company earned 283.23bn from its operations for a Cash Flow Margin of 14.03%. In addition the company used 190.54bn on investing activities and also paid 60.26bn in financing cash flows.
Cash flow per share | 435.15 |
---|---|
Price/Cash flow per share | 18.59 |
Book value per share | 4,829.27 |
---|---|
Tangible book value per share | 3,260.09 |
More ▼
Balance sheet in JPYView more
Current ratio | 2.07 |
---|---|
Quick ratio | 1.66 |
Total debt/total equity | 0.0946 |
---|---|
Total debt/total capital | 0.0851 |
More ▼
Growth rates in JPY
Year on year, growth in dividends per share increased 10.00% while earnings per share excluding extraordinary items fell by -9.19%. The positive trend in dividend payments is noteworthy since very few companies in the Major Drugs industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg) | 2.22% |
---|---|
Div growth rate (5 year) | 1.92% |
Payout ratio (TTM) | 51.36% |
EPS growth(5 years) | 8.18 |
---|---|
EPS (TTM) vs TTM 1 year ago | -23.94 |
More ▼